PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CELL SENESCENCE DISEASES COMPRISING HSA-MIR-371A-3P

摘要

The present invention relates to a pharmaceutical composition for preventing or treating a cellular senescence disease containing hsa-miR-371a-3p represented by a nucleotide sequence of SEQ ID No. 1. According to the present invention, when hsa-miR-371a-3p derived from a human is transfected into a human fibroblast cloned and aged, cellular senescence activity of an aged cell is confirmed to be reduced and cell growth is confirmed to be increased. Therefore, a composition containing hsa-miR-371a-3p according to the present invention as an active ingredient can be used as a pharmaceutical composition for treating a cellular senescence disease, a health food composition for alleviating a cellular senescence disease, and a cosmetic composition for alleviating skin aging.